Author:
Checa M.A.,Requena A.,Salvador C.,Tur R.,Callejo J.,Espinós J.J.,Fábregues F.,Herrero J.,
Publisher
Oxford University Press (OUP)
Subject
Obstetrics and Gynaecology,Reproductive Medicine
Reference229 articles.
1. Acién P, Querada F, Matallín P, Villarroya E, López-Fernández JA, Acién M, Mauri M and Alfayate R (1999) Insulin, androgens, and obesity in women with and without polycystic ovary síndrome: a heterogeneous group of disorders. Fertil Steril72, 32–40.
2. Adashi EY, Hsueh AJ and Yen SS (1981) Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology108, 1441–1449.
3. American Diabetes Association (1998) Consensus development conference on insulin resistance. Diabetes Care21, 310–314.
4. Andersen P, Seljeflot I, Abdelnoor M, Arnesen H, Dale PO, Lovik A and Birkeland K (1995) Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism44, 611–616.
5. Anonymous (2000) Troglitazone withdrawn from market. Am J Health Syst Pharm57, 834.
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献